Induction Healthcare Group PLC Publication of Full Year Financial Results Delayed

RNS Number : 0437U

Induction Healthcare Group PLC

27 June 2024

 

Induction Healthcare Group Plc

 

Publication of Full Year Financial Results Delayed

 

London, UK - 27 June 2024: Induction Healthcare Group PLC ("Induction", the "Company", or the "Group"; AIM: INHC), a leading digital health platform driving transformation of healthcare systems, today announces that the Group's audited final results for the year ended 31 March 2024 ("Results") will not be published on 1 July 2024, the previously planned date.

 

As detailed in the full year trading update announced on 29 April, the Results are expected to be in line with market expectations and the delay is due to the audit process not having yet concluded.

 

The Group will announce its results no later than 8 July 2024.

 

Enquiries

 

Induction Christopher Samler, Chair Paul Tambeau, Chief Executive Officer	[phone] [phone]
Singer Capital Markets (Nominated Adviser and Broker)	[phone]
Philip Davies Alaina Wong Jalini Kalaravy

 

About Induction - www.inductionhealthcare.com

Induction (AIM: INHC) Induction delivers a suite of software solutions that transforms care delivery and the patient journey through hospital. Our system-wide applications help healthcare providers and administrators to deliver care at any stage remotely as well as face-to-face - giving the communities they serve greater flexibility, control and ease of access. Purpose-built for integration with leading Electronic Medical Record (EMR) platforms, our products offer immediate stand-alone value that becomes even greater when integrated with pre-existing systems. 

 

Used at scale by national and regional healthcare systems, as well non-health government services, our applications are relied upon by hundreds of thousands of clinicians and millions of patients across almost every hospital in the British Isles. 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NORFFMRTMTTTBPI